Home » Authors » Nuala Moran

Articles by Nuala Moran

Astex, Aventis Collaborate On Drug-Metabolizing Enzymes

April 3, 2002

British Biotech Receives FDA Approval For BB-10153 Trial

April 3, 2002

Vernalis Seeks Second Nasdaq Listing, Reports Profitability

March 27, 2002

ReGen’s Phase IIa Interim Data Not Significant In Alzheimer’s

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

Avidex Platform Creates TCRs; Company Planning Partnerships

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

Avidex Platform Creates TCRs; Company Planning Partnerships

March 27, 2002

ReGen’s Phase IIa Interim Data Not Significant In Alzheimer’s

March 27, 2002

Vernalis Seeks Second Nasdaq Listing, Reports Profitability

March 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...